Profectus Biosciences
About:
Profectus Biosciences is a R&D company developing vaccine and small molecules to treat and prevent viral diseases and cancers.
Website: http://www.profectusbiosciences.com
Top Investors: Cross Atlantic Capital Partners
Description:
Profectus Biosciences is a research and development company dedicated to harnessing the immune system to treat and prevent viral diseases and cancers through the delivery of our proprietary prime/boost vaccines and small molecules.
Total Funding Amount:
$34.7M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Baltimore, Maryland, United States
Founded Date:
2002-01-01
Contact Email:
info(AT)profectusbiosciences.com
Founders:
Robert Charles Gallo, Timothy Fouts
Number of Employees:
11-50
Last Funding Date:
2015-12-09
IPO Status:
Private
Industries:
© 2025 bioDAO.ai